New Data Suggest Novartis Drug Gleevec(TM) (Formerly STI571) Effective In Rare Form of Gastrointestinal Tumor
(PR Newswire)Novartis Oncology today announced that data on the activity of Gleevec(TM) in a rare form of gastrointestinal stromal tumor will be highlighted during the key plenary session of the 37th annual meeting of the American Society for Clinical Oncology in San Francisco, California.- May 13 12:00 PM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010513/nysu003.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines